Dear reader,
|
Having said this, I became increasingly interested in global health as I learned more about it. What surprised me was what the mainstream media does—and doesn’t—pay attention to on this topic. Of course, the “topic de jour” in the media world today is potential outbreaks of communicable diseases like bird flu. Don’t get me wrong. If we have a mass pandemic, that’s extremely serious and the way the world community is working together on these threats is an inspiring story in itself.
But, the #1 killers in the world today are cardiovascular diseases (CVDs), causing around 17.5 million deaths a year. As one of the stories in this issue
|
Share your thoughts on the best buys for global health in Perspectives’ new Community Space!
|
Old or not, are resources really going to where they would do the most good? That’s the primary question this e-zine examines. One of the main problems in global healthcare today is the lack of money devoted to it. Billionaire Warren Buffett’s surprising donation to the Gates Foundation in late June is a very welcome development. But the facts remain: pharmaceutical companies are looking to make profits, many governments don’t make healthcare a priority, those in poorer countries can rarely afford expensive treatment options, and international private and public institutions still struggle to fill in the gaps. Under this reality, what interventions can save the most lives?
|
Special thanks to our expert
reviewer for this issue, Dr. Anthony R. Measham, a consultant on
international health, nutrition, and population programs who has done
work for the World Bank and National Institutes of Health.
|
Zarrin T. Caldwell
Editor, OneWorld Perspectives
PERSPECTIVES: BEST BUYS FOR GLOBAL HEALTH Homepage